CSIMarket
 
Creative Medical Technology Holdings Inc   (CELZ)
Other Ticker:  
 
 
Price: $4.2800 $0.25 6.203%
Day's High: $4.28 Week Perf: -0.7 %
Day's Low: $ 3.97 30 Day Perf: 0.71 %
Volume (M): 4 52 Wk High: $ 7.01
Volume (M$): $ 16 52 Wk Avg: $3.53
Open: $4.03 52 Wk Low: $0.40



 Market Capitalization (Millions $) 6
 Shares Outstanding (Millions) 1
 Employees -
 Revenues (TTM) (Millions $) 0
 Net Income (TTM) (Millions $) -10
 Cash Flow (TTM) (Millions $) -12
 Capital Exp. (TTM) (Millions $) 7

Creative Medical Technology Holdings Inc
Creative Medical Technology Holdings Inc. is a biotechnology company that focuses on developing and commercializing stem cell-based therapies and products to treat various medical conditions. The company's innovative approach involves using stem cells derived from the patient's own adipose tissue to develop personalized treatments. The therapies are aimed at addressing conditions like erectile dysfunction, immune system disorders, and degenerative conditions of the spine, among others. Creative Medical Technology Holdings Inc. aims to bring much-needed advancements in regenerative medicine to improve patient outcomes and quality of life.


   Company Address: 211 E Osborn Road Phoenix 85012 AZ
   Company Phone Number: 399-2822   Stock Exchange / Ticker: NASDAQ CELZ
   CELZ is expected to report next financial results on March 30, 2024.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Creative Medical Technology Holdings Inc

Creative Medical Technology Holdings Inc. Plunges as Q3 2023 Results Reveal Devastating Financial Performance

Financial News Report: CELZ Reports Disastrous Q3 2023; Stock Drops by 0.96% in 5 Trading Days
Creative Medical Technology Holdings Inc. (CELZ) recently reported a disastrous third quarter of 2023, with a significant decline in revenue and an increase in net loss per share compared to the same period a year ago. The company's revenue faded by -89.091% to $0.01 million, while net loss per share swelled to $-1.02, from the corresponding reporting period in the previous year.
For the fiscal time-frame closing September 30, 2023, Creative Medical Technology Holdings Inc. realized a net deficit of $-1.454 million, a significant increase from the $-0.982 million reported in the same period a year ago. The larger net deficit indicates a worsening financial performance for the company.

Creative Medical Technology Holdings Inc

Creative Medical Technology Holdings Inc wows Shareholders as Second Quarter Financial Report reveals remarkable $-1.192038 million Operating Shortfall Turnaround


Subtitle: Second Quarter Financials Show Promising Signs for Industry Leader As Shares Dip
As an industry analyst closely monitoring the Biotechnology & Pharmaceuticals sector, I find the recent financial results reported by Creative Medical Technology Holdings Inc particularly intriguing. Despite the lack of revenue mentioned for the second quarter of 2023, it is evident that the company has made significant strides in improving its cost-effectiveness, leading to a decreased operating shortfall compared to the same period last year.
The latest figures reveal an operating shortfall of $-1.192038 million for the April to June 30, 2023 reporting period. This represents a substantial improvement from the operating shortfall of $-1.791144 million recorded in the second quarter of 2022. Though losses still persist, the fact that they have reduced to $-1.102 million indicates a positive trajectory for the Company.

Creative Medical Technology Holdings Inc

Creative Medical Technology Holdings Inc Shows Promising Improvement with Reduced Losses in First Quarter of 2023

Creative Medical Technology Holdings Inc, a medical technology company, has reported their financial results for the first quarter of 2023. The company has decreased their loss per share from $-0.18 to $-0.07 compared to the same quarter a year ago. Additionally, their earnings per share have improved from $-0.24 to $-0.07 from the prior quarter of 2022.
The revenue for Creative Medical Technology Holdings Inc remained unchanged at $0.00 million compared to the same quarter a year ago, and sequentially from the prior quarter of 2022, which was $0.02 million. This indicates that the company has been maintaining its revenue streams, although it has not seen any growth in this area.






 

Creative Medical Technology Holdings Inc's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com